In vivo study found that delphinidin treatment reduced tumor growth induced by B16-F10 melanoma cell xenograft by preventing VEGF-induced proliferation and activation of ERK 1/2 and p38 MAP kinase through a mechanism sensitive to PI3/AKT inhibitors [137]. This evidence concerns the gene AKT1 and melanoma.